nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—DRD4—Gilles de la Tourette syndrome	0.27	0.343	CbGaD
Quetiapine—DRD3—Gilles de la Tourette syndrome	0.232	0.295	CbGaD
Quetiapine—DRD2—Gilles de la Tourette syndrome	0.161	0.204	CbGaD
Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.124	0.158	CbGaD
Quetiapine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00357	0.0596	CbGeAlD
Quetiapine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00223	0.0372	CbGeAlD
Quetiapine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00124	0.0207	CbGeAlD
Quetiapine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0199	CbGeAlD
Quetiapine—DRD4—brain—Gilles de la Tourette syndrome	0.0011	0.0183	CbGeAlD
Quetiapine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00109	0.0181	CbGeAlD
Quetiapine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00105	0.0175	CbGeAlD
Quetiapine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00101	0.0169	CbGeAlD
Quetiapine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000972	0.0162	CbGeAlD
Quetiapine—HTR6—nervous system—Gilles de la Tourette syndrome	0.000972	0.0162	CbGeAlD
Quetiapine—HTR1E—brain—Gilles de la Tourette syndrome	0.000947	0.0158	CbGeAlD
Quetiapine—DRD5—nervous system—Gilles de la Tourette syndrome	0.000946	0.0158	CbGeAlD
Quetiapine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.000936	0.0156	CbGeAlD
Quetiapine—DRD5—central nervous system—Gilles de la Tourette syndrome	0.000911	0.0152	CbGeAlD
Quetiapine—H1F0—midbrain—Gilles de la Tourette syndrome	0.00089	0.0149	CbGeAlD
Quetiapine—DRD1—midbrain—Gilles de la Tourette syndrome	0.000879	0.0147	CbGeAlD
Quetiapine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000849	0.0142	CbGeAlD
Quetiapine—CHRM4—brain—Gilles de la Tourette syndrome	0.00083	0.0139	CbGeAlD
Quetiapine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000817	0.0136	CbGeAlD
Quetiapine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000776	0.013	CbGeAlD
Quetiapine—DRD3—brain—Gilles de la Tourette syndrome	0.000772	0.0129	CbGeAlD
Quetiapine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.000759	0.0127	CbGeAlD
Quetiapine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000747	0.0125	CbGeAlD
Quetiapine—HTR6—brain—Gilles de la Tourette syndrome	0.000743	0.0124	CbGeAlD
Quetiapine—H1F0—nervous system—Gilles de la Tourette syndrome	0.000732	0.0122	CbGeAlD
Quetiapine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00073	0.0122	CbGeAlD
Quetiapine—DRD5—brain—Gilles de la Tourette syndrome	0.000723	0.0121	CbGeAlD
Quetiapine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000723	0.0121	CbGeAlD
Quetiapine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000712	0.0119	CbGeAlD
Quetiapine—H1F0—central nervous system—Gilles de la Tourette syndrome	0.000705	0.0118	CbGeAlD
Quetiapine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000698	0.0117	CbGeAlD
Quetiapine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000696	0.0116	CbGeAlD
Quetiapine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00069	0.0115	CbGeAlD
Quetiapine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000683	0.0114	CbGeAlD
Quetiapine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000672	0.0112	CbGeAlD
Quetiapine—CHRM5—brain—Gilles de la Tourette syndrome	0.000649	0.0108	CbGeAlD
Quetiapine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000593	0.0099	CbGeAlD
Quetiapine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000586	0.00978	CbGeAlD
Quetiapine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000583	0.00973	CbGeAlD
Quetiapine—ADRA1D—brain—Gilles de la Tourette syndrome	0.00058	0.00968	CbGeAlD
Quetiapine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000575	0.0096	CbGeAlD
Quetiapine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000567	0.00947	CbGeAlD
Quetiapine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000564	0.00942	CbGeAlD
Quetiapine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000562	0.00938	CbGeAlD
Quetiapine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000561	0.00937	CbGeAlD
Quetiapine—H1F0—brain—Gilles de la Tourette syndrome	0.00056	0.00934	CbGeAlD
Quetiapine—DRD1—brain—Gilles de la Tourette syndrome	0.000553	0.00923	CbGeAlD
Quetiapine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000549	0.00918	CbGeAlD
Quetiapine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000546	0.00912	CbGeAlD
Quetiapine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000541	0.00903	CbGeAlD
Quetiapine—HTR3A—brain—Gilles de la Tourette syndrome	0.000534	0.00891	CbGeAlD
Quetiapine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00053	0.00886	CbGeAlD
Quetiapine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00052	0.00868	CbGeAlD
Quetiapine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000511	0.00853	CbGeAlD
Quetiapine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000505	0.00843	CbGeAlD
Quetiapine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000475	0.00793	CbGeAlD
Quetiapine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000473	0.00789	CbGeAlD
Quetiapine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000457	0.00763	CbGeAlD
Quetiapine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000455	0.0076	CbGeAlD
Quetiapine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000452	0.00754	CbGeAlD
Quetiapine—HTR1B—brain—Gilles de la Tourette syndrome	0.000448	0.00748	CbGeAlD
Quetiapine—CHRM2—brain—Gilles de la Tourette syndrome	0.000445	0.00744	CbGeAlD
Quetiapine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000436	0.00728	CbGeAlD
Quetiapine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000435	0.00726	CbGeAlD
Quetiapine—HTR1D—brain—Gilles de la Tourette syndrome	0.000433	0.00724	CbGeAlD
Quetiapine—HTR2C—brain—Gilles de la Tourette syndrome	0.000429	0.00717	CbGeAlD
Quetiapine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000427	0.00713	CbGeAlD
Quetiapine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000419	0.00701	CbGeAlD
Quetiapine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000415	0.00693	CbGeAlD
Quetiapine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000411	0.00687	CbGeAlD
Quetiapine—CHRM1—brain—Gilles de la Tourette syndrome	0.000405	0.00677	CbGeAlD
Quetiapine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000403	0.00673	CbGeAlD
Quetiapine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.0004	0.00668	CbGeAlD
Quetiapine—CHRM3—brain—Gilles de la Tourette syndrome	0.000363	0.00606	CbGeAlD
Quetiapine—HTR1A—brain—Gilles de la Tourette syndrome	0.000361	0.00603	CbGeAlD
Quetiapine—Flupentixol—DRD2—Gilles de la Tourette syndrome	0.000351	0.0471	CrCbGaD
Quetiapine—HTR7—brain—Gilles de la Tourette syndrome	0.000345	0.00577	CbGeAlD
Quetiapine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000343	0.00572	CbGeAlD
Quetiapine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000337	0.00563	CbGeAlD
Quetiapine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000333	0.00556	CbGeAlD
Quetiapine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000331	0.00553	CbGeAlD
Quetiapine—DRD2—brain—Gilles de la Tourette syndrome	0.000326	0.00545	CbGeAlD
Quetiapine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000325	0.00542	CbGeAlD
Quetiapine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000319	0.00533	CbGeAlD
Quetiapine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000317	0.0053	CbGeAlD
Quetiapine—Olanzapine—DRD4—Gilles de la Tourette syndrome	0.000315	0.0422	CrCbGaD
Quetiapine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000312	0.0418	CrCbGaD
Quetiapine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000282	0.0047	CbGeAlD
Quetiapine—Olanzapine—DRD3—Gilles de la Tourette syndrome	0.000271	0.0364	CrCbGaD
Quetiapine—Flupentixol—HTR2A—Gilles de la Tourette syndrome	0.000271	0.0364	CrCbGaD
Quetiapine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000271	0.00453	CbGeAlD
Quetiapine—Nefazodone—SLC6A3—Gilles de la Tourette syndrome	0.000264	0.0354	CrCbGaD
Quetiapine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000261	0.00436	CbGeAlD
Quetiapine—HRH1—brain—Gilles de la Tourette syndrome	0.000258	0.00431	CbGeAlD
Quetiapine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000257	0.00429	CbGeAlD
Quetiapine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000253	0.00423	CbGeAlD
Quetiapine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000251	0.00419	CbGeAlD
Quetiapine—Amoxapine—DRD4—Gilles de la Tourette syndrome	0.000251	0.0336	CrCbGaD
Quetiapine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000247	0.00413	CbGeAlD
Quetiapine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000235	0.0315	CrCbGaD
Quetiapine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000225	0.00375	CbGeAlD
Quetiapine—Amoxapine—DRD3—Gilles de la Tourette syndrome	0.000216	0.029	CrCbGaD
Quetiapine—HTR2A—brain—Gilles de la Tourette syndrome	0.000215	0.0036	CbGeAlD
Quetiapine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000212	0.0285	CrCbGaD
Quetiapine—Amoxapine—SLC6A3—Gilles de la Tourette syndrome	0.000201	0.027	CrCbGaD
Quetiapine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000197	0.0265	CrCbGaD
Quetiapine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000196	0.00328	CbGeAlD
Quetiapine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000196	0.0263	CrCbGaD
Quetiapine—Olanzapine—DRD2—Gilles de la Tourette syndrome	0.000188	0.0252	CrCbGaD
Quetiapine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000185	0.00308	CbGeAlD
Quetiapine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000178	0.00297	CbGeAlD
Quetiapine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000176	0.0236	CrCbGaD
Quetiapine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000173	0.0232	CrCbGaD
Quetiapine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.00017	0.0228	CrCbGaD
Quetiapine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.00017	0.0228	CrCbGaD
Quetiapine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.000169	0.0226	CrCbGaD
Quetiapine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000164	0.022	CrCbGaD
Quetiapine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000163	0.0218	CrCbGaD
Quetiapine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000157	0.0211	CrCbGaD
Quetiapine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000152	0.0205	CrCbGaD
Quetiapine—Nefazodone—HTR2A—Gilles de la Tourette syndrome	0.000152	0.0203	CrCbGaD
Quetiapine—Amoxapine—DRD2—Gilles de la Tourette syndrome	0.00015	0.0201	CrCbGaD
Quetiapine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000147	0.0197	CrCbGaD
Quetiapine—Olanzapine—HTR2A—Gilles de la Tourette syndrome	0.000145	0.0195	CrCbGaD
Quetiapine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000142	0.019	CrCbGaD
Quetiapine—ABCB1—brain—Gilles de la Tourette syndrome	0.000141	0.00236	CbGeAlD
Quetiapine—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.00014	0.0188	CrCbGaD
Quetiapine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000134	0.0179	CrCbGaD
Quetiapine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000131	0.0176	CrCbGaD
Quetiapine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000131	0.0176	CrCbGaD
Quetiapine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000118	0.0158	CrCbGaD
Quetiapine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000117	0.0157	CrCbGaD
Quetiapine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000116	0.0156	CrCbGaD
Quetiapine—Amoxapine—HTR2A—Gilles de la Tourette syndrome	0.000116	0.0155	CrCbGaD
Quetiapine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0152	CrCbGaD
Quetiapine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000105	0.0141	CrCbGaD
Quetiapine—Clozapine—DRD2—Gilles de la Tourette syndrome	9.81e-05	0.0132	CrCbGaD
Quetiapine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	9.08e-05	0.0122	CrCbGaD
Quetiapine—Loxapine—HTR2A—Gilles de la Tourette syndrome	9.02e-05	0.0121	CrCbGaD
Quetiapine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.012	CrCbGaD
Quetiapine—Promazine—HTR2A—Gilles de la Tourette syndrome	8.1e-05	0.0109	CrCbGaD
Quetiapine—Clozapine—HTR2A—Gilles de la Tourette syndrome	7.58e-05	0.0102	CrCbGaD
Quetiapine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000204	CbGpPWpGaD
Quetiapine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.96e-05	0.000203	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.95e-05	0.000203	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.91e-05	0.000199	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.89e-05	0.000198	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.88e-05	0.000198	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.86e-05	0.000196	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.84e-05	0.000195	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.84e-05	0.000195	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000194	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000193	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.81e-05	0.000193	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000192	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.78e-05	0.000191	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.78e-05	0.000191	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.78e-05	0.000191	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.76e-05	0.000189	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000189	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000186	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000186	CbGpPWpGaD
Quetiapine—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.7e-05	0.000185	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.7e-05	0.000185	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.69e-05	0.000184	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.68e-05	0.000184	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.67e-05	0.000183	CbGpPWpGaD
Quetiapine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.6e-05	0.000179	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.59e-05	0.000178	CbGpPWpGaD
Quetiapine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.59e-05	0.000178	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000178	CbGpPWpGaD
Quetiapine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000177	CbGpPWpGaD
Quetiapine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.57e-05	0.000177	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.57e-05	0.000176	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000176	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.55e-05	0.000175	CbGpPWpGaD
Quetiapine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000175	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000174	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	2.53e-05	0.000174	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.53e-05	0.000173	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.53e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.52e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.52e-05	0.000173	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.52e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.51e-05	0.000172	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.48e-05	0.00017	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	2.47e-05	0.00017	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.45e-05	0.000168	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.44e-05	0.000168	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.44e-05	0.000167	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.43e-05	0.000166	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.42e-05	0.000166	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.41e-05	0.000165	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.36e-05	0.000162	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000162	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.000162	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000162	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.35e-05	0.000161	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.35e-05	0.000161	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.33e-05	0.00016	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.32e-05	0.000159	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.32e-05	0.000159	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.31e-05	0.000159	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.31e-05	0.000158	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.000158	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.000158	CbGpPWpGaD
Quetiapine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000157	CbGpPWpGaD
Quetiapine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000157	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.29e-05	0.000157	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.29e-05	0.000157	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.28e-05	0.000156	CbGpPWpGaD
Quetiapine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000156	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.28e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.27e-05	0.000156	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.27e-05	0.000156	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.25e-05	0.000154	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.25e-05	0.000154	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.24e-05	0.000154	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.24e-05	0.000153	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.000153	CbGpPWpGaD
Quetiapine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.23e-05	0.000153	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.21e-05	0.000151	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.2e-05	0.000151	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.2e-05	0.000151	CbGpPWpGaD
Quetiapine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000151	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.19e-05	0.00015	CbGpPWpGaD
Quetiapine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.000148	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.000147	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000146	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.11e-05	0.000145	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000144	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.1e-05	0.000144	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.1e-05	0.000144	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.1e-05	0.000144	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000144	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.09e-05	0.000143	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.000143	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000143	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000143	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000143	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000142	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.08e-05	0.000142	CbGpPWpGaD
Quetiapine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000142	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000142	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.07e-05	0.000142	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.06e-05	0.000141	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000141	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.05e-05	0.000141	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.00014	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.00014	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.04e-05	0.00014	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.03e-05	0.000139	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.000139	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000139	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.01e-05	0.000138	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2e-05	0.000137	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.000137	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.000135	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000135	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000134	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.95e-05	0.000134	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000133	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.94e-05	0.000133	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.93e-05	0.000132	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.91e-05	0.000131	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.000131	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.000131	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.9e-05	0.00013	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.00013	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.00013	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.89e-05	0.000129	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000129	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.87e-05	0.000128	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.87e-05	0.000128	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.86e-05	0.000128	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.000127	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.86e-05	0.000127	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	1.84e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.83e-05	0.000126	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.83e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.8e-05	0.000124	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.79e-05	0.000123	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000122	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000121	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000121	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.000121	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.76e-05	0.000121	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.76e-05	0.00012	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.76e-05	0.00012	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.74e-05	0.00012	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.73e-05	0.000119	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.71e-05	0.000117	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.7e-05	0.000117	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.7e-05	0.000117	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.000116	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000115	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.67e-05	0.000115	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.66e-05	0.000114	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.65e-05	0.000113	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000113	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.62e-05	0.000111	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000111	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.6e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.6e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.00011	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.59e-05	0.000109	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.59e-05	0.000109	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.54e-05	0.000106	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.53e-05	0.000105	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.52e-05	0.000105	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.51e-05	0.000104	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.49e-05	0.000102	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.49e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000102	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.49e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.47e-05	0.000101	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.0001	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.0001	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.45e-05	9.98e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.45e-05	9.92e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.44e-05	9.88e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.44e-05	9.87e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.44e-05	9.86e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.43e-05	9.82e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.4e-05	9.58e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.39e-05	9.55e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.39e-05	9.53e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.37e-05	9.4e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.35e-05	9.29e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.35e-05	9.27e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.35e-05	9.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.16e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.33e-05	9.12e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.12e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.33e-05	9.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.32e-05	9.06e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.31e-05	8.97e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.3e-05	8.95e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.3e-05	8.92e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.29e-05	8.88e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.26e-05	8.66e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.26e-05	8.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.24e-05	8.52e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.24e-05	8.51e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.24e-05	8.5e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.24e-05	8.48e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.23e-05	8.45e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.23e-05	8.44e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.23e-05	8.43e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.23e-05	8.41e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.22e-05	8.38e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.22e-05	8.37e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.22e-05	8.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.21e-05	8.32e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.21e-05	8.28e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	8.26e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	8.23e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	8.21e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.2e-05	8.2e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.18e-05	8.13e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.18e-05	8.1e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.18e-05	8.07e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	7.96e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.13e-05	7.76e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	7.71e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	7.69e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	7.67e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.11e-05	7.64e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.11e-05	7.63e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.1e-05	7.57e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.1e-05	7.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.1e-05	7.53e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.06e-05	7.27e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.05e-05	7.17e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.05e-05	7.17e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.02e-05	7.01e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.44e-06	6.47e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.11e-06	6.25e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.06e-06	6.22e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.82e-06	6.05e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.68e-06	5.95e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8e-06	5.49e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.85e-06	5.39e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.83e-06	5.37e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.8e-06	5.35e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.73e-06	5.3e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.71e-06	5.29e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.16e-06	4.91e-05	CbGpPWpGaD
